CPS All-Star Showcase Returns to UC's Fifth Third Arena, Saturday, March 30

UC partners with Cincinnati Public Schools to highlight top students, support Project Connect

What: Tickets are now on sale for the Cincinnati Public Schools (CPS) All-Star Showcase, presented by the University of Cincinnati. The third annual Showcase returns to Fifth Third Arena to highlight the accomplishments of top student-athletes through individual and team competitions.

During the showcase, fans can enjoy CPS’ top athletes competing in skills challenges, slam dunk contests, and the All-Star game.The event will also recognize the most recent Marian Spencer Scholars and CPS Athletics Hall of Fame inductees.

The Showcase raises funds for Project Connect, CPS’ program to advocate and provide specialized academic services and lifestyle enrichment opportunities for children experiencing homelessness. The event will also feature a community, college and career fair. 

When: Saturday, March 30, 2024 from 12-noon until 7:30 p.m.

Where: UC's Fifth Third Arena, 2700 O’Varsity Way, Cincinnati, Ohio 45221 

Cost: General Admission tickets are available for purchase for $20, with CPS students receiving a 50% coupon code. VIP tickets are available through a sponsorship package of $400 or more, which includes five VIP tickets and one parking pass.

Parking is available for $5.

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.